Skip to main content
Show — Main navigation
Hide — Main navigation
Hair & Scalp
Coping During COVID
Centers of Excellence
Expert Insights in Derm
AAD Summer Meeting
SDPA Fall Conference
AAD VMX 2020
GW Advances in Acne
San Diego Dermatology Symposium
Centers of Excellence
Novel Topical Therapy Effective for Molluscum Contagiosum
Findings from a recent study showed a drug-device combination product containing cantharidin, 0.7%, was safe and effective for patients with molluscum contagiosum.
Study Investigates the Efficacy of Lasers for Nonmelanoma Skin Cancers
Findings from a recent study highlighted whether Nd:YAG laser, CO2 laser, or pulse dye laser were effective for preventing recurrence of nonmelanoma skin cancers.
Rituximab Associated With Some Cardiac Adverse Effects Among Patients With Pemphigus
A recent study found rituximab infusions were associated with changes in heart rate and other cardiac adverse effects among patients with pemphigus.
Biologic Therapies Associated With Reductions in High-Risk Coronary Plaque
Findings from a recent study showed biologic treatments were able to reduce coronary artery plaque lipid-rich necrotic core, which is associated with higher risk of cardiovascular events.
Metabolic Status Does Not Affect the Efficacy, Safety of a Biologic
Findings from a post hoc analysis of two clinical trials showed improvements on psoriasis severity were comparable between patients with and without metabolic syndrome.
Topical Foam Effective for Proactive Management of Psoriasis
A recent clinical trial showed a topical foam was safe and effective for proactively managing psoriasis for 52 weeks.
Dermal Tunnels Negatively Impact Time to Clinical Response
Findings from a recent study showed the presence of dermal tunnels affected time to clinical response, as well as time to loss of response, among patients with hidradenitis suppurativa treated with adalimumab.
Long-term Dupilumab Use Safe and Effective for Refractory AD
Findings from a recent study showed dupilumab was safe and effective for treating treatment-resistant atopic dermatitis over a year in a real-world setting.
Melanoma Risk Still High for Patients Treated With Immune Checkpoint Inhibitors
Findings from a recent study suggest patients with metastatic melanoma treated immune checkpoint inhibitors are still at risk of developing new primary cutaneous melanoma.
Which Factors Affect Palmoplantar Pustulosis Severity?
A recent study highlighted factors, including smoking status, that affected disease severity among two large cohorts of patients with palmoplantar pustulosis.
Stay in the know.
The Dermatologist Newsletter
Back to Top